Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: heparin

June 14, 2023 CD as API / CD derivatives / Pharma applications

A sugammadex-analogue, per-6-O-carboxyhexyl-thio-gamma-CD (OKL-1111) is a highly potent and universal reversal agent for anticoagulants

Antithrombotic therapy is undoubtedly associated with a risk for bleeding and these bleeding complications sometimes can be life-threatening. Recently, specific

Continue reading

February 23, 2023 Drug delivery / Pharma applications

Heparin: The Journey from Parenteral Agent to Nasal Delivery

Although the worldwide usage of direct oral anticoagulants has continuously increased over the past decade, heparin remains an important weapon

Continue reading

March 2, 2021 CD derivatives / Drug delivery / Pharma applications

Heptakis(6-amino-6-deoxy)-beta-cyclodextrin stabilizes the synthetic anticoagulant fondaparinux

The intermolecular interactions between the cationic per-6-amino-b-CD with the highly anionic heparin analogue anticoagulant fondaparinux were studied at two different

Continue reading

June 27, 2019 E-ducation

Carbohydrate drugs (Part 6) (Polysaccharides)

Polysaccharides are polymeric carbohydrate structures. The monomers are linked via glycosidic bonds. Some common examples are starch, glycogen or cellulose.

Continue reading

July 30, 2018 CD derivatives

Phosphates of cyclodextrin polymers

The synthesis of β-CD polymer phosphate sodium salts was worked out to be used for coating of metal-organic framework (MOF)

Continue reading

Recent Posts

  • Self-Disinfecting Food Coatings: Light-Activated Antimicrobial Surfaces
  • Can a Cyclodextrin Really Stop Body Odor by Quorum Quenching?
  • Disruption of Lipid Sorting and Endosomal Transport in Cyclodextrin-mediated Cytotoxicity
  • 4th International Aquatic Biotechnology Symposium
  • Cyclodextrin metal-organic framework engineered titanium surface: Targeted modulation of foam cell lipid homeostasis and inflammatory resolution

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (352)
  • CD derivatives (428)
  • Cosmetics and toilettry (53)
  • Diagnosis (13)
  • Drug delivery (806)
  • E-ducation (63)
  • Environmental (143)
  • Events (237)
  • Food (231)
  • Gene delivery (22)
  • Household products (5)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (44)
  • Non-pharma applications (412)
  • Other industrial use (111)
  • Pharma applications (1,206)
  • Supramolecular systems (44)
  • Uncategorized (164)

Top Posts

  • Can a Cyclodextrin Really Stop Body Odor by Quorum Quenching?
  • Self-Disinfecting Food Coatings: Light-Activated Antimicrobial Surfaces
  • Disruption of Lipid Sorting and Endosomal Transport in Cyclodextrin-mediated Cytotoxicity
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • The monograph of SBECD is official in the European Pharmacopeia
  • Lanosterol eye drops for cataract treatment
  • Cyclodextrins as Multi-Functional Ingredients in Dentistry
  • Bridion® injection now approved for patients of all ages
  • OCULIS ANNOUNCES AN OVERSUBSCRIBED US$57 MILLION SERIES C FINANCING
  • Cyclodextrin metal-organic framework engineered titanium surface: Targeted modulation of foam cell lipid homeostasis and inflammatory resolution

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...